Novel Nano-Sized MR Contrast Agent Mediates Strong Tumor Contrast Enhancement in an Oncogene-Driven Breast Cancer Model

• Per-Olof Eriksson,

  Affiliation Spago Nanomedical, Lund, Sweden

  ⨯
• Emil Aaltonen ,

  * E-mail: emil.aaltonen@spagoimaging.se

  Affiliation Spago Nanomedical, Lund, Sweden

  ⨯
• Rodrigo Petoral Jr,

  Affiliation Spago Nanomedical, Lund, Sweden

  ⨯
• Petter Lauritzson,

  Affiliation Spago Nanomedical, Lund, Sweden

  ⨯
• Hideki Miyazaki,

  Affiliation Department of Laboratory Medicine Lund, Division of Translational Cancer Research, Lund University, Lund, Sweden

  ⨯
• Kristian Pietras,

  Affiliations Department of Laboratory Medicine Lund, Division of Translational Cancer Research, Lund University, Lund, Sweden, Department of Medical Biochemistry and Biophysics, Division of Vascular Biology, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Sven Månsson,

  Affiliation Department of Medical Radiation Physics, Lund University, Skåne University Hospital, Malmö, Sweden

  ⨯
• Lennart Hansson,

  Affiliation Spago Nanomedical, Lund, Sweden

  ⨯
• Peter Leander,

  Affiliation Department of Radiology, Lund University, Skåne University Hospital, Malmö, Sweden

  ⨯
• Oskar Axelsson

  Affiliation Spago Nanomedical, Lund, Sweden

  ⨯